Literature DB >> 12577098

Naegleria meningitis: a rare survival.

R Jain1, S Prabhakar, M Modi, R Bhatia, R Sehgal.   

Abstract

Acute amebic meningoencephalitis caused by free-living amebae naegleria fowleri is extremely rare and uniformly fatal with only seven survivals reported till date. An interesting case of naegleria meningitis diagnosed by wet mount cytology of cerebrospinal fluid (CSF) and treated with amphoterecin B, rifampicin and ornidazole with complete recovery is presented. In cases of suspected pyogenic meningitis, if CSF staining, antigen detection or culture is negative for bacteria, a wet mount cytology of CSF for naegleria is suggested. Early treatment with amphoterecin B and rifampicin may improve survival.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12577098

Source DB:  PubMed          Journal:  Neurol India        ISSN: 0028-3886            Impact factor:   2.117


  23 in total

1.  PCR-based diagnosis of Naegleria sp. infection in formalin-fixed and paraffin-embedded brain sections.

Authors:  Marc Schild; Christian Gianinazzi; Bruno Gottstein; Norbert Müller
Journal:  J Clin Microbiol       Date:  2006-11-22       Impact factor: 5.948

2.  Emerging and reemerging neurologic infections.

Authors:  Felicia C Chow; Carol A Glaser
Journal:  Neurohospitalist       Date:  2014-10

3.  Synergistic activities of azithromycin and amphotericin B against Naegleria fowleri in vitro and in a mouse model of primary amebic meningoencephalitis.

Authors:  Shannon M Soltow; George M Brenner
Journal:  Antimicrob Agents Chemother       Date:  2006-10-23       Impact factor: 5.191

Review 4.  Neuroparasitic infections: cestodes, trematodes, and protozoans.

Authors:  M D Walker; J R Zunt
Journal:  Semin Neurol       Date:  2005-09       Impact factor: 3.420

5.  Youngest survivor of naegleria meningitis.

Authors:  Dinesh Yadav; Satinder Aneja; Renu Dutta; Anu Maheshwari; Anju Seth
Journal:  Indian J Pediatr       Date:  2012-04-28       Impact factor: 1.967

Review 6.  Importance of nonenteric protozoan infections in immunocompromised people.

Authors:  J L N Barratt; J Harkness; D Marriott; J T Ellis; D Stark
Journal:  Clin Microbiol Rev       Date:  2010-10       Impact factor: 26.132

Review 7.  Review of clinical presentations in Thai patients with primary amoebic meningoencephalitis.

Authors:  Viroj Wiwanitkit
Journal:  MedGenMed       Date:  2004-03-08

8.  Activity of Auranofin against Multiple Genotypes of Naegleria fowleri and Its Synergistic Effect with Amphotericin B In Vitro.

Authors:  Jose Ignacio Escrig; Hye Jee Hahn; Anjan Debnath
Journal:  ACS Chem Neurosci       Date:  2020-05-26       Impact factor: 4.418

9.  Corifungin, a new drug lead against Naegleria, identified from a high-throughput screen.

Authors:  Anjan Debnath; Josefino B Tunac; Silvia Galindo-Gómez; Angélica Silva-Olivares; Mineko Shibayama; James H McKerrow
Journal:  Antimicrob Agents Chemother       Date:  2012-08-06       Impact factor: 5.191

10.  Naegleria fowleri after 50 years: is it a neglected pathogen?

Authors:  Moisés Martínez-Castillo; Roberto Cárdenas-Zúñiga; Daniel Coronado-Velázquez; Anjan Debnath; Jesús Serrano-Luna; Mineko Shibayama
Journal:  J Med Microbiol       Date:  2016-07-04       Impact factor: 2.472

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.